Skip navigation

Uniting Payers, Providers and Manufacturers to Increase Market Access and Identify Value Ecosystems for Mature and Emerging Oncologic Therapies

February 28-March 1, 2018
  • San Francisco, CA

The Industry’s Longest-Running Oncology Market Access Event is Back!

CBI’s 11th Annual Oncology Market Access Strategy Summit convenes key stakeholders involved in commercializing new-to-market drugs and refreshing mature therapeutics. From manufacturers and payers, to healthcare providers, join your industry counterparts as they benchmark best practices to streamline market access and promote commercial success.

As the marketplace makes room for new and diverse treatment options, it is more important than ever to have a clear “go-to-market strategy” for oncology therapies. Today’s crowded marketplace and slim margins expose manufacturers to poor market performance and commercial failure if a well-developed market access strategy is not executed.

This year’s Oncology Market Access Strategy Summit ensures manufacturers have the tools needed to identify value networks early in the product lifecycle and confirm proper reimbursement channels are in place.

Featuring Industry Hot Topics:

  • Increase Market Access Through Progressive
    Stakeholder Partnerships
  • Learn to Adapt Your Market Access Strategy to Engage
    Any of the Wide Ranging Oncology Payment Models
  • Respond to Evolving Pricing and Reimbursement Models
  • Develop Strategies to Successfully Gain Formulary Access
  • Bridge the Gap Between Discovery and Commercial Success

PREVIOUS ATTENDEE ACCLAIM:

This conference has a great line-up of speakers and the conference atmosphere enabled excellent discussion.

Global Head, Pricing, Market Access & Policy, Biosimilars, Merck

The conference provided the knowledge I was anticipating and looking for. I appreciated the level of different topics that provided solutions to the issues and challenges faced today
by manufacturers utilizing co-pay off-set strategies.

VP, Industry Relations & Managed Markets, City Drugs Specialty Pharmacy

Excellent appraisal of approaches and philosophies
in market access and engagement.

Senior Director, Quality Strategic Consumer Group, Janssen

A cost-effective way to learn from thought leaders, peers and vendors in a topic area of interest. Especially useful at
the beginning of the year to set performance goals and
think of new approaches to explore during the year.

Assistant Director, Payer Marketing, Acorda Therapeutics

11th Annual Oncology Market Access Strategy Summit

Uniting Payers, Providers and Manufacturers to Increase Market Access and Identify Value Ecosystems for Mature and Emerging Oncologic Therapies

The Industry’s Longest-Running Oncology Market Access Event is Back!

CBI’s 11th Annual Oncology Market Access Strategy Summit convenes key stakeholders involved in commercializing new-to-market drugs and refreshing mature therapeutics. From manufacturers and payers, to healthcare providers, join your industry counterparts as they benchmark best practices to streamline market access and promote commercial success.

As the marketplace makes room for new and diverse treatment options, it is more important than ever to have a clear “go-to-market strategy” for oncology therapies. Today’s crowded marketplace and slim margins expose manufacturers to poor market performance and commercial failure if a well-developed market access strategy is not executed.

This year’s Oncology Market Access Strategy Summit ensures manufacturers have the tools needed to identify value networks early in the product lifecycle and confirm proper reimbursement channels are in place.

Featuring Industry Hot Topics:

  • Increase Market Access Through Progressive
    Stakeholder Partnerships
  • Learn to Adapt Your Market Access Strategy to Engage
    Any of the Wide Ranging Oncology Payment Models
  • Respond to Evolving Pricing and Reimbursement Models
  • Develop Strategies to Successfully Gain Formulary Access
  • Bridge the Gap Between Discovery and Commercial Success

PREVIOUS ATTENDEE ACCLAIM:

This conference has a great line-up of speakers and the conference atmosphere enabled excellent discussion.

Global Head, Pricing, Market Access & Policy, Biosimilars, Merck

The conference provided the knowledge I was anticipating and looking for. I appreciated the level of different topics that provided solutions to the issues and challenges faced today
by manufacturers utilizing co-pay off-set strategies.

VP, Industry Relations & Managed Markets, City Drugs Specialty Pharmacy

Excellent appraisal of approaches and philosophies
in market access and engagement.

Senior Director, Quality Strategic Consumer Group, Janssen

A cost-effective way to learn from thought leaders, peers and vendors in a topic area of interest. Especially useful at
the beginning of the year to set performance goals and
think of new approaches to explore during the year.

Assistant Director, Payer Marketing, Acorda Therapeutics